ARCHIVES

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Mark Israel To Direct Norris Cotton Center

October 19, 2001

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001